Synthesis and characterization of tritium‐labeled RU486
- 1 December 1995
- journal article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 36 (12) , 1199-1203
- https://doi.org/10.1002/jlcr.2580361210
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical Use of Mifepristone (RU 486)Annals of Medicine, 1993
- Characterization and Functional Properties of the A and B Forms of Human Progesterone Receptors Synthesized in a Baculovirus SystemMolecular Endocrinology, 1991
- Treatment of breast cancer with different antiprogestins: Preclinical and clinical studiesThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Mammalian Progesterone Receptor Shows Differential Sensitivity to Sulfhydryl Group Modifying Agents When Bound to Agonist and Antagonist LigandsJournal of Biological Chemistry, 1989
- Transformation of human progesterone receptor in the presence of the progestin (R5020) and the antiprogestin (RU486)The Journal of Steroid Biochemistry and Molecular Biology, 1988
- Evidence for separate binding sites for progesterone and RU486 in the chick oviductBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1986
- Induction of menstruation by an antiprogesterone steroid (RU 486) in primates: site of action, dose-response relationships, and hormonal effectsFertility and Sterility, 1983
- 204. RU 38486 — A potent antiprogesteroneJournal of Steroid Biochemistry, 1982